文章摘要
全红飞.血清TWEAK、LTB4水平与儿童功能性消化不良的关系分析[J].安徽医药,待发表.
血清TWEAK、LTB4水平与儿童功能性消化不良的关系分析
投稿时间:2026-09-11  录用日期:2026-11-17
DOI:
中文关键词: 功能性消化不良  儿童  肿瘤坏死因子样弱凋亡诱导因子  白三烯B4  炎症  临床症状严重程度
英文关键词: 
基金项目:河北省医学科学研究课题计划项目,编号:20261027
作者单位邮编
全红飞* 唐山市妇幼保健院 063000
摘要点击次数: 0
全文下载次数: 0
中文摘要:
      目的:探讨血清肿瘤坏死因子样弱凋亡诱导因子(TWEAK)、白三烯B4(LTB4)水平与儿童功能性消化不良(FD)的关系,分析二者与FD临床症状严重程度的相关性。方法:选取2025年1月至2026年3月于唐山市妇幼保健院儿科门诊就诊的FD患儿78例作为研究组,同期选取健康体检儿童80例作为对照组。采用酶联免疫吸附试验(ELISA)检测血清TWEAK、LTB4及超敏C反应蛋白(hs-CRP)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平。采用症状评分量表评估FD患儿临床症状严重程度。比较两组血清TWEAK、LTB4水平差异,分析其与炎性指标的相关性,采用限制性立方样条(RCS)模型分析血清TWEAK、LTB4水平与症状总分的非线性关系。结果:研究组血清TWEAK、LTB4及hs-CRP、IL-6、TNF-α水平均显著高于对照组(P<0.05)。Pearson相关分析显示,FD患儿血清TWEAK、LTB4水平与hs-CRP、IL-6、TNF-α均呈显著正相关(P<0.05)。多因素Logistic回归分析显示,血清TWEAK(OR=1.052,95% CI:1.028~1.077)、血清LTB4(OR=1.048,95% CI:1.022~1.075)及家族消化系统疾病史(OR=2.856,95% CI:1.210~6.739)是FD发生的关联因素(P<0.05)。随临床症状严重程度增加,FD患儿血清TWEAK、LTB4水平逐渐升高,重度组显著高于中度组和轻度组(P<0.05)。RCS分析显示,血清TWEAK、LTB4水平与症状总分呈线性正相关(Pfor overall<0.001,Pfor nonlinear>0.05)。结论:血清TWEAK、LTB4水平升高与儿童FD的发生密切相关,二者水平随临床症状严重程度增加而升高,可能成为儿童FD辅助诊断及病情评估的潜在生物标志物。
英文摘要:
      Objective: To explore the relationship between levels of serum tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and leukotriene B4 (LTB4) and functional dyspepsia (FD) in children, and to analyze the correlation between these two factors and the severity of clinical symptoms of FD. Methods: From January 2025 to March 2026, 78 children with FD who visited the pediatric outpatient department of Tangshan Maternal and Child Health Hospital were designated as the research group, and 80 healthy children who underwent physical exams were as the control group. The levels of serum TWEAK, LTB4, high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were detected by enzyme-linked immunosorbent assay (ELISA). The severity of clinical symptoms in children with FD was evaluated using a symptom scoring scale. The differences in serum TWEAK and LTB4 levels between the two groups were compared, and their correlations with inflammatory indicators were analyzed. In addition, the nonlinear relationship between levels of serum TWEAK and LTB4 and the total symptom score was analyzed using the restricted cubic spline (RCS) model. Results: The levels of serum TWEAK, LTB4, hs-CRP, IL-6, and TNF-α in the study group were obviously higher than those in the control group (P < 0.05). Pearson correlation analysis showed that serum TWEAK and LTB4 in children with FD were obviously positively correlated with hs-CRP, IL-6, and TNF-α (P < 0.05). The multivariate Logistic regression analysis revealed that serum TWEAK (OR = 1.052, 95% CI: 1.028-1.077), serum LTB4 (OR = 1.048, 95% CI: 1.022-1.075), and family history of digestive system diseases (OR = 2.856, 95% CI: 1.210-6.739) were associated factors for the occurrence of FD (P < 0.05). As the severity of clinical symptoms increased, the levels of serum TWEAK and LTB4 in children with FD gradually increased, and the levels in the severe group were significantly higher than those in the moderate and mild groups (P < 0.05). In addition, RCS analysis showed that serum TWEAK and LTB4 were linearly and positively correlated with the total symptom score (P for overall < 0.001, P for nonlinear > 0.05). Conclusion: Elevated levels of serum TWEAK and LTB4 are closely associated with the occurrence of FD in children. The levels of these two increase with the worsen of severity of clinical symptoms, and they may serve as potential biomarkers for the auxiliary diagnosis and disease assessment of FD in children.
  查看/发表评论  下载PDF阅读器
关闭